Claims for Patent: 8,324,232

Summary for Patent: 8,324,232

Title:	4-pyrimidinesulfamide derivative
Abstract:	The invention relates to the compound of structural formula (I) and the salts thereof. Said compound is useful as endothelin receptor antagonist. The invention further relates to a process for preparing said compound.
Inventor(s):	Bolli Martin, Boss Christoph, Treiber Alexander
Assignee:	Actelion Pharmaceuticals Ltd.
Application Number:	US12673413
Patent Claims:	2. A compound of formula I as defined in claim 1 , or a pharmaceutically acceptable salt thereof.3. A pharmaceutical composition containing claim 1 , as active principle claim 1 , the compound of formula I as defined in or a pharmaceutically acceptable salt thereof claim 1 , and at least one therapeutically inert excipient.4. A method for the treatment of hypertension comprising administering to a patient in need thereof claim 1 , a pharmaceutically effective amount of a compound according to claim 1 , or a pharmaceutically acceptable salt form.5. A method for the treatment of pulmonary hypertension comprising administering to a patient in need thereof claim 1 , a pharmaceutically effective amount of a compound according to claim 1 , or a pharmaceutically acceptable salt form.6. A method for the treatment of pulmonary arterial hypertension comprising administering to a patient in need thereof claim 1 , a pharmaceutically effective amount of a compound according to claim 1 , or a pharmaceutically acceptable salt form.